The relationship between fatigue and depression, and event-related potentials in epileptics

Epilepsy and Behavior

Volumn 8, Issue 3, 2006, Pages 581-587

  Soyuer, Ferhan ^a   Erdoǧan, Füsun ^a   Şenol, Vesile ^a   Arman, Fehim ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Depression; Epilepsy: fatigue; Event related potentials

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EPILEPSY; EVENT RELATED POTENTIAL; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; RATING SCALE; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; COGNITION; DEPRESSION; ELECTROENCEPHALOGRAPHY; EPILEPSY; EVENT-RELATED POTENTIALS, P300; FATIGUE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 33646085334     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2006.01.013     Document Type: Article

References (52)

1. Chaudhuri A., and Behan P.O. Fatigue in neurological disorders. Lancet 363 (2004) 978-988
2. Schwid S.R., Covington M., Segal B.M., and Goodman A.D. Fatigue in multiple sclerosis: current understanding and future directions. J Rehabil Res Dev 39 (2002) 211-221
3. Krupp L.B., Alvarez L.A., LaRocca N.G., and Scheinberg L.C. Fatigue in multiple sclerosis. Arch Neurol 45 (1988) 435-437
4. Piper B.F., Lindsey A.M., and Dodd M.J. Fatigue mechanisms in cancer patients: developing nursing theory. Oncol Nurs Forum 14 (1987) 17-23
5. Pepper C.M., Krupp L.B., Friedberg F., Doscher C., and Coyle P.K. A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression. J Neuropsychiatry Clin Neurosci 5 (1993) 200-205
6. Kroenke K., Wood D.R., Mangelsdorff A.D., Meier N.J., and Powel J.B. Chronic fatigue in primary care: prevalence, patient characteristics and outcome. JAMA 260 (1988) 929-934
7. Freal J.G., Kraft G.H., and Coryell J.K. Symptomatic fatigue in multiple sclerosis. Arch Phys Med Rehabil 5 (1984) 135-137
8. Krupp L.B., Alvarez L.A., LaRocca N.G., and Scheinberg L. Clinical characteristics of fatigue in multiple sclerosis. Arch Neurol 45 (1988) 435-437
9. Friedman J., and Friedman H. Fatigue in Parkinson's disease. Neurology 43 (1993) 2016-2028
10. Berll M.H., Strauser W.W., and Hall K.M. Fatigue in postpolio syndrome. Arch Phys Med Rehabil 72 (1991) 115-118
11. Merkies IS, Schmitz PI, Samijn JP, van der Meche FG, van Doorn PA, for the European Inflammatory Neuropathy Cause and Treatment (INCAT) Group. Fatigue in immune-mediated polyneuropathies. Neurology 1999;53:1648-54.
12. Krupp L.B., LaRocca N.G., Muir J., and Steinberg A.D. A study of fatigue in systemic lupus erythematosus. J Rheumatol 17 (1990) 1450-1452
13. Krupp L.B., Schwartz J.E., and Jandorf L. Fatigue in Lyme disease. In: Coyle P.K. (Ed). Lyme disease (1993), Mosby Year Book, St. Louis, MO 196-203
14. Sanjac M., Brinkmann J., Belden D.S., et al. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. J Neurol Sci 191 (2001) 55-59
15. Ingles J.L., Eskes G.A., and Philips S.J. Fatigue after stroke. Arch Phys Med Rehabil 80 (1999) 173-178
16. Ettinger A.B., Weisbrot D.M., Krupp L.B., Coyle P.K., Jandorf L., and Devinsky O. Fatigue and depression in epilepsy. J Epilepsy 11 (1998) 105-109
17. Devinsky O. Therapy for neurobehavioral disorders in epilepsy. Epilepsia 45 (2004) 34-40
18. Frucht M.M., Quigg M., Schwaner C., and Fountain N.B. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 41 (2000) 1534-1539
19. Lambert M.V., and Robertson M.M. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia 40 (1999) S21-S47
20. Kanner A.M. Depression in epilepsy: a frequently neglected multifaceted disorder. Epilepsy Behav 4 (2003) 11-19
21. Mohr D.C., Classen C., and Barrera J.M. The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychol Med 34 (2004) 533-541
22. Krupp L.B., LaRocca N.G., and Muir-Nash J. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46 (1989) 1121-1123
23. Ford H., Trigwell P., and Johnson M. The nature of fatigue in multiple sclerosis. J Psychosom Res 45 (1998) 33-38
24. Donchin E., and Coles M.H. Is the P300 component a manifestation of context updating?. Brain Behav Sci 11 (1988) 357-374
25. Patterson J.V., Mikaleski H.J., and Starr A. Latency variability of the components of auditory event related potentials to infrequent stimuli in aging. Alzheimer type dementia and depression. Electroencephalogr Clin Neurophysiol 71 (1988) 450-460
26. Wu X., Sun J.L., and Rou B.Y. Event-related potential and intelligence test performance of 50 patients with epilepsy. Clin Electroencephalogr 28 (1997) 32-35
27. Naganuma Y., Konishi K., Hongou K., Okada T., and Tohyama J. Event-related potentials (P300) and EEG activity in childhood partial epilepsy. Brain Dev 19 (1997) 117-121
28. Neshige R., and Lüders H. Identification of a negative bitemporal component (P300) of the event-related potentials demonstrated by noncephalic recording. Neurology 38 (1988) 1803-1805
29. Starr A., and Barret G. Disordered auditory short-term memory in man and event-related potentials. Brain 110 (1987) 935-959
30. Pelosi L., Holly M., Slade T., Hayware M., Barrett G., and Blumhardt L.D. Event-related potential (ERP) correlates of performance of intelligence tests. Electroencephalogr Clin Neurophysiol 84 (1992) 515-520
31. Sandroni P., Walker C., and Starr A. Fatigue in patients with multiple sclerosis: motor pathway conduction and event-related potentials. Arch Neurol 49 (1992) S17-S24
32. Kaseda Y., Jiang C., Katsumi K., Mimori Y., and Nakamura S. Objective evaluation of fatigue by event-related potentials. J Neurol Sci 158 (1998) 96-100
33. Polich J., Moore A.P., and Wiederhold M.D. P300 assessment of chronic fatigue syndrome. J Clin Neurophysiol 12 (1995) 186-191
34. Austin M.P., Mitchell P., and Goodwin G.M. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 178 (2001) 200-206
35. Brody A.L., Barsom M.W., Bota R.G., and Saxena S. Prefrontal-subcortical and limbic circuit mediation of major depressive disorders. Semin Clin Neuropsychiatry 6 (2001) 102-112
36. Rao S.M. Neuropsychology of multiple sclerosis. Curr Opin Neurol 8 (1995) 216-220
37. Elixhauser A., Leidy N.K., Meador K., Means E., and Willian M.K. The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy. Epilepsy Res 37 (1999) 13-24
38. Paradiso S., Hermann B.P., Blumer D., and Davies K. Impact of depressed mood on neuropsychological status in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 70 (2001) 180-185
39. Bruder G.E., Towey J.P., Stewart J.W., and Friedman D. Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P300 latency. Biol Psychiatry 30 (1991) 233-246
40. Plooij-Van Gorsel E. Evoked potential correlates of information processing and habituation in depressive illness. Ann NY Acad Sci 425 (1984) 609-617
41. Di Traglia G., and Polich J. P300 in major depressive disorder. Psychiatry Res 15 (1985) 175-184
42. Gangadhar B.N., Ancy J., Janakiramaiah N., and Umapathy C. P300 amplitude in non-bipolar, melancholic depression. J Aff Disord 28 (1993) 57-60
43. Beck A.T., Ward Ch., and Mendelson M. An inventory for measuring depression. Arch Gen Psychiatry 4 (1961) 561-571
44. Motamedi G., and Meador K. Epilepsy and cognition. Epilepsy Behav 4 (2003) S25-S38
45. Meador K. Cognitive outcomes and predictive factors in epilepsy. Neurology 58 (2002) S21-S26
46. Funk S.G. Key aspect of comfort: management of pain, fatigue, and nausea (1989), Springer, New York
47. Mattson R.H., Cramer J.A., and Collins J.F. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic seizures. N Engl J Med 313 (1985) 145-151
48. Marson A.G., Kadir Z.A., and Hutton J.L. The new antiepileptic drugs: systematic review of their efficacy and tolerability. Epilepsia 38 (1997) 859-880
49. Vermeulen J., and Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 22 (1995) 65-95
50. Carpay J.A., Aldenkamp A.P., and van Donselaar C.A. Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure 14 (2005) 198-206
51. Triantafyllou N.I., Zalonis I., Kokotis P., Anthracopoulos M., Siafacas A., and Malliara S. Cognition in epilepsy: a multichannel event related potential (P300) study. Acta Neurol Scand 86 (1992) 462-465
52. Panjwani U., Singh S.H., Gupta H.L., Mukhopadhyay S., and Thakur L. Brainstem auditory evoked potentials in epileptics on different anti-epileptics drugs. Indian J Physiol Pharmacol 40 (1996) 29-34